nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—CHRM3—Carbachol—glaucoma	0.085	0.131	CbGbCtD
Paroxetine—CHRM3—Pilocarpine—glaucoma	0.0791	0.122	CbGbCtD
Paroxetine—CHRM1—Carbachol—glaucoma	0.074	0.114	CbGbCtD
Paroxetine—CHRM1—Pilocarpine—glaucoma	0.0688	0.106	CbGbCtD
Paroxetine—CHRM2—Carbachol—glaucoma	0.0682	0.105	CbGbCtD
Paroxetine—CHRM2—Pilocarpine—glaucoma	0.0634	0.0976	CbGbCtD
Paroxetine—SLC6A2—Clonidine—glaucoma	0.0377	0.058	CbGbCtD
Paroxetine—CYP2D6—Carteolol—glaucoma	0.0305	0.047	CbGbCtD
Paroxetine—CYP2D6—Betaxolol—glaucoma	0.0206	0.0317	CbGbCtD
Paroxetine—CYP2C9—Diclofenamide—glaucoma	0.0198	0.0305	CbGbCtD
Paroxetine—CYP2C9—Dorzolamide—glaucoma	0.0192	0.0295	CbGbCtD
Paroxetine—CYP2C9—Methazolamide—glaucoma	0.0171	0.0263	CbGbCtD
Paroxetine—CYP2D6—Methazolamide—glaucoma	0.0156	0.024	CbGbCtD
Paroxetine—ABCB1—Timolol—glaucoma	0.0141	0.0217	CbGbCtD
Paroxetine—CYP2D6—Timolol—glaucoma	0.0133	0.0204	CbGbCtD
Paroxetine—ABCB1—Clonidine—glaucoma	0.012	0.0184	CbGbCtD
Paroxetine—CYP2D6—Clonidine—glaucoma	0.0113	0.0174	CbGbCtD
Paroxetine—Gastrointestinal disorder—Pilocarpine—glaucoma	8.08e-05	0.000283	CcSEcCtD
Paroxetine—Gastrointestinal pain—Travoprost—glaucoma	8.07e-05	0.000283	CcSEcCtD
Paroxetine—Loss of consciousness—Clonidine—glaucoma	8.05e-05	0.000282	CcSEcCtD
Paroxetine—Feeling abnormal—Brinzolamide—glaucoma	8.03e-05	0.000282	CcSEcCtD
Paroxetine—Mental disorder—Betaxolol—glaucoma	8.03e-05	0.000282	CcSEcCtD
Paroxetine—Pain—Pilocarpine—glaucoma	8.01e-05	0.000281	CcSEcCtD
Paroxetine—Constipation—Pilocarpine—glaucoma	8.01e-05	0.000281	CcSEcCtD
Paroxetine—Cough—Clonidine—glaucoma	7.99e-05	0.00028	CcSEcCtD
Paroxetine—Sweating—Timolol—glaucoma	7.99e-05	0.00028	CcSEcCtD
Paroxetine—Dizziness—Apraclonidine—glaucoma	7.99e-05	0.00028	CcSEcCtD
Paroxetine—Erythema—Betaxolol—glaucoma	7.98e-05	0.00028	CcSEcCtD
Paroxetine—Malnutrition—Betaxolol—glaucoma	7.98e-05	0.00028	CcSEcCtD
Paroxetine—Urticaria—Dorzolamide—glaucoma	7.87e-05	0.000276	CcSEcCtD
Paroxetine—Epistaxis—Timolol—glaucoma	7.86e-05	0.000276	CcSEcCtD
Paroxetine—Abdominal pain—Dorzolamide—glaucoma	7.83e-05	0.000275	CcSEcCtD
Paroxetine—Body temperature increased—Dorzolamide—glaucoma	7.83e-05	0.000275	CcSEcCtD
Paroxetine—Tension—Betaxolol—glaucoma	7.83e-05	0.000274	CcSEcCtD
Paroxetine—Sinusitis—Timolol—glaucoma	7.82e-05	0.000274	CcSEcCtD
Paroxetine—Dysgeusia—Betaxolol—glaucoma	7.81e-05	0.000274	CcSEcCtD
Paroxetine—Chest pain—Clonidine—glaucoma	7.8e-05	0.000274	CcSEcCtD
Paroxetine—Arthralgia—Clonidine—glaucoma	7.8e-05	0.000274	CcSEcCtD
Paroxetine—Abdominal pain—Travoprost—glaucoma	7.8e-05	0.000274	CcSEcCtD
Paroxetine—Agranulocytosis—Timolol—glaucoma	7.78e-05	0.000273	CcSEcCtD
Paroxetine—Anxiety—Clonidine—glaucoma	7.77e-05	0.000273	CcSEcCtD
Paroxetine—Asthenia—Acetazolamide—glaucoma	7.76e-05	0.000272	CcSEcCtD
Paroxetine—Dizziness—Bimatoprost—glaucoma	7.75e-05	0.000272	CcSEcCtD
Paroxetine—Nervousness—Betaxolol—glaucoma	7.75e-05	0.000272	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	7.75e-05	0.000272	CcSEcCtD
Paroxetine—Urticaria—Brinzolamide—glaucoma	7.74e-05	0.000271	CcSEcCtD
Paroxetine—Feeling abnormal—Pilocarpine—glaucoma	7.72e-05	0.000271	CcSEcCtD
Paroxetine—Discomfort—Clonidine—glaucoma	7.71e-05	0.00027	CcSEcCtD
Paroxetine—Vomiting—Apraclonidine—glaucoma	7.68e-05	0.000269	CcSEcCtD
Paroxetine—Muscle spasms—Betaxolol—glaucoma	7.67e-05	0.000269	CcSEcCtD
Paroxetine—Gastrointestinal pain—Pilocarpine—glaucoma	7.66e-05	0.000268	CcSEcCtD
Paroxetine—Hypersensitivity—Brimonidine—glaucoma	7.64e-05	0.000268	CcSEcCtD
Paroxetine—Dry mouth—Clonidine—glaucoma	7.63e-05	0.000268	CcSEcCtD
Paroxetine—Bradycardia—Timolol—glaucoma	7.62e-05	0.000267	CcSEcCtD
Paroxetine—Dermatitis—Apraclonidine—glaucoma	7.61e-05	0.000267	CcSEcCtD
Paroxetine—Headache—Apraclonidine—glaucoma	7.57e-05	0.000266	CcSEcCtD
Paroxetine—Confusional state—Clonidine—glaucoma	7.54e-05	0.000264	CcSEcCtD
Paroxetine—Vision blurred—Betaxolol—glaucoma	7.52e-05	0.000264	CcSEcCtD
Paroxetine—Rhinitis—Timolol—glaucoma	7.5e-05	0.000263	CcSEcCtD
Paroxetine—Oedema—Clonidine—glaucoma	7.48e-05	0.000262	CcSEcCtD
Paroxetine—Tremor—Betaxolol—glaucoma	7.47e-05	0.000262	CcSEcCtD
Paroxetine—Hallucination—Timolol—glaucoma	7.45e-05	0.000261	CcSEcCtD
Paroxetine—Asthenia—Brimonidine—glaucoma	7.44e-05	0.000261	CcSEcCtD
Paroxetine—Infection—Clonidine—glaucoma	7.43e-05	0.00026	CcSEcCtD
Paroxetine—Body temperature increased—Pilocarpine—glaucoma	7.4e-05	0.00026	CcSEcCtD
Paroxetine—Abdominal pain—Pilocarpine—glaucoma	7.4e-05	0.00026	CcSEcCtD
Paroxetine—Ill-defined disorder—Betaxolol—glaucoma	7.4e-05	0.00026	CcSEcCtD
Paroxetine—Diarrhoea—Acetazolamide—glaucoma	7.4e-05	0.000259	CcSEcCtD
Paroxetine—Rash—Bimatoprost—glaucoma	7.39e-05	0.000259	CcSEcCtD
Paroxetine—Dermatitis—Bimatoprost—glaucoma	7.38e-05	0.000259	CcSEcCtD
Paroxetine—Oedema peripheral—Timolol—glaucoma	7.37e-05	0.000259	CcSEcCtD
Paroxetine—Anaemia—Betaxolol—glaucoma	7.37e-05	0.000259	CcSEcCtD
Paroxetine—Shock—Clonidine—glaucoma	7.36e-05	0.000258	CcSEcCtD
Paroxetine—Connective tissue disorder—Timolol—glaucoma	7.36e-05	0.000258	CcSEcCtD
Paroxetine—Pruritus—Brimonidine—glaucoma	7.34e-05	0.000257	CcSEcCtD
Paroxetine—Headache—Bimatoprost—glaucoma	7.34e-05	0.000257	CcSEcCtD
Paroxetine—Nervous system disorder—Clonidine—glaucoma	7.33e-05	0.000257	CcSEcCtD
Paroxetine—Thrombocytopenia—Clonidine—glaucoma	7.32e-05	0.000257	CcSEcCtD
Paroxetine—Hypersensitivity—Dorzolamide—glaucoma	7.3e-05	0.000256	CcSEcCtD
Paroxetine—Tachycardia—Clonidine—glaucoma	7.3e-05	0.000256	CcSEcCtD
Paroxetine—Hypersensitivity—Travoprost—glaucoma	7.27e-05	0.000255	CcSEcCtD
Paroxetine—Skin disorder—Clonidine—glaucoma	7.26e-05	0.000255	CcSEcCtD
Paroxetine—Hyperhidrosis—Clonidine—glaucoma	7.23e-05	0.000253	CcSEcCtD
Paroxetine—Visual impairment—Timolol—glaucoma	7.21e-05	0.000253	CcSEcCtD
Paroxetine—Malaise—Betaxolol—glaucoma	7.19e-05	0.000252	CcSEcCtD
Paroxetine—Nausea—Apraclonidine—glaucoma	7.18e-05	0.000252	CcSEcCtD
Paroxetine—Hypersensitivity—Brinzolamide—glaucoma	7.18e-05	0.000252	CcSEcCtD
Paroxetine—Vertigo—Betaxolol—glaucoma	7.17e-05	0.000251	CcSEcCtD
Paroxetine—Syncope—Betaxolol—glaucoma	7.15e-05	0.000251	CcSEcCtD
Paroxetine—Dizziness—Acetazolamide—glaucoma	7.15e-05	0.000251	CcSEcCtD
Paroxetine—Asthenia—Dorzolamide—glaucoma	7.11e-05	0.000249	CcSEcCtD
Paroxetine—Asthenia—Travoprost—glaucoma	7.08e-05	0.000248	CcSEcCtD
Paroxetine—Palpitations—Betaxolol—glaucoma	7.05e-05	0.000247	CcSEcCtD
Paroxetine—Pruritus—Dorzolamide—glaucoma	7.01e-05	0.000246	CcSEcCtD
Paroxetine—Loss of consciousness—Betaxolol—glaucoma	7.01e-05	0.000246	CcSEcCtD
Paroxetine—Eye disorder—Timolol—glaucoma	7e-05	0.000245	CcSEcCtD
Paroxetine—Asthenia—Brinzolamide—glaucoma	6.99e-05	0.000245	CcSEcCtD
Paroxetine—Hypotension—Clonidine—glaucoma	6.99e-05	0.000245	CcSEcCtD
Paroxetine—Pruritus—Travoprost—glaucoma	6.98e-05	0.000245	CcSEcCtD
Paroxetine—Tinnitus—Timolol—glaucoma	6.98e-05	0.000245	CcSEcCtD
Paroxetine—Cough—Betaxolol—glaucoma	6.96e-05	0.000244	CcSEcCtD
Paroxetine—Nausea—Bimatoprost—glaucoma	6.96e-05	0.000244	CcSEcCtD
Paroxetine—Cardiac disorder—Timolol—glaucoma	6.95e-05	0.000244	CcSEcCtD
Paroxetine—Hypersensitivity—Pilocarpine—glaucoma	6.9e-05	0.000242	CcSEcCtD
Paroxetine—Pruritus—Brinzolamide—glaucoma	6.89e-05	0.000242	CcSEcCtD
Paroxetine—Vomiting—Acetazolamide—glaucoma	6.87e-05	0.000241	CcSEcCtD
Paroxetine—Dizziness—Brimonidine—glaucoma	6.86e-05	0.000241	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Clonidine—glaucoma	6.81e-05	0.000239	CcSEcCtD
Paroxetine—Angiopathy—Timolol—glaucoma	6.79e-05	0.000238	CcSEcCtD
Paroxetine—Myalgia—Betaxolol—glaucoma	6.79e-05	0.000238	CcSEcCtD
Paroxetine—Arthralgia—Betaxolol—glaucoma	6.79e-05	0.000238	CcSEcCtD
Paroxetine—Chest pain—Betaxolol—glaucoma	6.79e-05	0.000238	CcSEcCtD
Paroxetine—Diarrhoea—Dorzolamide—glaucoma	6.78e-05	0.000238	CcSEcCtD
Paroxetine—Headache—Acetazolamide—glaucoma	6.77e-05	0.000237	CcSEcCtD
Paroxetine—Anxiety—Betaxolol—glaucoma	6.77e-05	0.000237	CcSEcCtD
Paroxetine—Insomnia—Clonidine—glaucoma	6.76e-05	0.000237	CcSEcCtD
Paroxetine—Immune system disorder—Timolol—glaucoma	6.76e-05	0.000237	CcSEcCtD
Paroxetine—Diarrhoea—Travoprost—glaucoma	6.75e-05	0.000237	CcSEcCtD
Paroxetine—Mediastinal disorder—Timolol—glaucoma	6.75e-05	0.000237	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	6.74e-05	0.000236	CcSEcCtD
Paroxetine—Asthenia—Pilocarpine—glaucoma	6.72e-05	0.000236	CcSEcCtD
Paroxetine—Paraesthesia—Clonidine—glaucoma	6.71e-05	0.000235	CcSEcCtD
Paroxetine—Discomfort—Betaxolol—glaucoma	6.71e-05	0.000235	CcSEcCtD
Paroxetine—Arrhythmia—Timolol—glaucoma	6.69e-05	0.000234	CcSEcCtD
Paroxetine—Dyspnoea—Clonidine—glaucoma	6.67e-05	0.000234	CcSEcCtD
Paroxetine—Diarrhoea—Brinzolamide—glaucoma	6.67e-05	0.000234	CcSEcCtD
Paroxetine—Somnolence—Clonidine—glaucoma	6.65e-05	0.000233	CcSEcCtD
Paroxetine—Dry mouth—Betaxolol—glaucoma	6.64e-05	0.000233	CcSEcCtD
Paroxetine—Pruritus—Pilocarpine—glaucoma	6.62e-05	0.000232	CcSEcCtD
Paroxetine—Alopecia—Timolol—glaucoma	6.61e-05	0.000232	CcSEcCtD
Paroxetine—Confusional state—Betaxolol—glaucoma	6.56e-05	0.00023	CcSEcCtD
Paroxetine—Mental disorder—Timolol—glaucoma	6.56e-05	0.00023	CcSEcCtD
Paroxetine—Dizziness—Dorzolamide—glaucoma	6.55e-05	0.00023	CcSEcCtD
Paroxetine—Rash—Brimonidine—glaucoma	6.54e-05	0.000229	CcSEcCtD
Paroxetine—Dermatitis—Brimonidine—glaucoma	6.54e-05	0.000229	CcSEcCtD
Paroxetine—Dizziness—Travoprost—glaucoma	6.52e-05	0.000229	CcSEcCtD
Paroxetine—Erythema—Timolol—glaucoma	6.52e-05	0.000229	CcSEcCtD
Paroxetine—Malnutrition—Timolol—glaucoma	6.52e-05	0.000229	CcSEcCtD
Paroxetine—Oedema—Betaxolol—glaucoma	6.51e-05	0.000228	CcSEcCtD
Paroxetine—Headache—Brimonidine—glaucoma	6.5e-05	0.000228	CcSEcCtD
Paroxetine—Decreased appetite—Clonidine—glaucoma	6.5e-05	0.000228	CcSEcCtD
Paroxetine—Infection—Betaxolol—glaucoma	6.47e-05	0.000227	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Clonidine—glaucoma	6.46e-05	0.000226	CcSEcCtD
Paroxetine—Fatigue—Clonidine—glaucoma	6.45e-05	0.000226	CcSEcCtD
Paroxetine—Dizziness—Brinzolamide—glaucoma	6.44e-05	0.000226	CcSEcCtD
Paroxetine—Nausea—Acetazolamide—glaucoma	6.42e-05	0.000225	CcSEcCtD
Paroxetine—Diarrhoea—Pilocarpine—glaucoma	6.41e-05	0.000225	CcSEcCtD
Paroxetine—Shock—Betaxolol—glaucoma	6.4e-05	0.000225	CcSEcCtD
Paroxetine—Tension—Timolol—glaucoma	6.39e-05	0.000224	CcSEcCtD
Paroxetine—Pain—Clonidine—glaucoma	6.39e-05	0.000224	CcSEcCtD
Paroxetine—Constipation—Clonidine—glaucoma	6.39e-05	0.000224	CcSEcCtD
Paroxetine—Nervous system disorder—Betaxolol—glaucoma	6.38e-05	0.000224	CcSEcCtD
Paroxetine—Dysgeusia—Timolol—glaucoma	6.38e-05	0.000224	CcSEcCtD
Paroxetine—Thrombocytopenia—Betaxolol—glaucoma	6.37e-05	0.000224	CcSEcCtD
Paroxetine—Tachycardia—Betaxolol—glaucoma	6.35e-05	0.000223	CcSEcCtD
Paroxetine—Nervousness—Timolol—glaucoma	6.33e-05	0.000222	CcSEcCtD
Paroxetine—Skin disorder—Betaxolol—glaucoma	6.32e-05	0.000222	CcSEcCtD
Paroxetine—Vomiting—Dorzolamide—glaucoma	6.3e-05	0.000221	CcSEcCtD
Paroxetine—Hyperhidrosis—Betaxolol—glaucoma	6.29e-05	0.000221	CcSEcCtD
Paroxetine—Rash—Dorzolamide—glaucoma	6.25e-05	0.000219	CcSEcCtD
Paroxetine—Dermatitis—Dorzolamide—glaucoma	6.24e-05	0.000219	CcSEcCtD
Paroxetine—Rash—Travoprost—glaucoma	6.22e-05	0.000218	CcSEcCtD
Paroxetine—Dermatitis—Travoprost—glaucoma	6.21e-05	0.000218	CcSEcCtD
Paroxetine—Headache—Dorzolamide—glaucoma	6.21e-05	0.000218	CcSEcCtD
Paroxetine—Vomiting—Brinzolamide—glaucoma	6.19e-05	0.000217	CcSEcCtD
Paroxetine—Dizziness—Pilocarpine—glaucoma	6.19e-05	0.000217	CcSEcCtD
Paroxetine—Headache—Travoprost—glaucoma	6.18e-05	0.000217	CcSEcCtD
Paroxetine—Nausea—Brimonidine—glaucoma	6.16e-05	0.000216	CcSEcCtD
Paroxetine—Feeling abnormal—Clonidine—glaucoma	6.16e-05	0.000216	CcSEcCtD
Paroxetine—Rash—Brinzolamide—glaucoma	6.14e-05	0.000215	CcSEcCtD
Paroxetine—Vision blurred—Timolol—glaucoma	6.14e-05	0.000215	CcSEcCtD
Paroxetine—Dermatitis—Brinzolamide—glaucoma	6.14e-05	0.000215	CcSEcCtD
Paroxetine—Gastrointestinal pain—Clonidine—glaucoma	6.11e-05	0.000214	CcSEcCtD
Paroxetine—Headache—Brinzolamide—glaucoma	6.1e-05	0.000214	CcSEcCtD
Paroxetine—Hypotension—Betaxolol—glaucoma	6.08e-05	0.000213	CcSEcCtD
Paroxetine—Angioedema—Timolol—glaucoma	5.95e-05	0.000209	CcSEcCtD
Paroxetine—Vomiting—Pilocarpine—glaucoma	5.95e-05	0.000209	CcSEcCtD
Paroxetine—Urticaria—Clonidine—glaucoma	5.94e-05	0.000208	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betaxolol—glaucoma	5.93e-05	0.000208	CcSEcCtD
Paroxetine—Abdominal pain—Clonidine—glaucoma	5.91e-05	0.000207	CcSEcCtD
Paroxetine—Body temperature increased—Clonidine—glaucoma	5.91e-05	0.000207	CcSEcCtD
Paroxetine—Rash—Pilocarpine—glaucoma	5.9e-05	0.000207	CcSEcCtD
Paroxetine—Dermatitis—Pilocarpine—glaucoma	5.9e-05	0.000207	CcSEcCtD
Paroxetine—Insomnia—Betaxolol—glaucoma	5.89e-05	0.000206	CcSEcCtD
Paroxetine—Nausea—Dorzolamide—glaucoma	5.89e-05	0.000206	CcSEcCtD
Paroxetine—Headache—Pilocarpine—glaucoma	5.87e-05	0.000206	CcSEcCtD
Paroxetine—Nausea—Travoprost—glaucoma	5.86e-05	0.000206	CcSEcCtD
Paroxetine—Vertigo—Timolol—glaucoma	5.85e-05	0.000205	CcSEcCtD
Paroxetine—Paraesthesia—Betaxolol—glaucoma	5.85e-05	0.000205	CcSEcCtD
Paroxetine—Syncope—Timolol—glaucoma	5.84e-05	0.000205	CcSEcCtD
Paroxetine—Dyspnoea—Betaxolol—glaucoma	5.8e-05	0.000204	CcSEcCtD
Paroxetine—Nausea—Brinzolamide—glaucoma	5.79e-05	0.000203	CcSEcCtD
Paroxetine—Palpitations—Timolol—glaucoma	5.76e-05	0.000202	CcSEcCtD
Paroxetine—Dyspepsia—Betaxolol—glaucoma	5.73e-05	0.000201	CcSEcCtD
Paroxetine—Loss of consciousness—Timolol—glaucoma	5.73e-05	0.000201	CcSEcCtD
Paroxetine—Cough—Timolol—glaucoma	5.69e-05	0.000199	CcSEcCtD
Paroxetine—Decreased appetite—Betaxolol—glaucoma	5.66e-05	0.000198	CcSEcCtD
Paroxetine—Hypertension—Timolol—glaucoma	5.63e-05	0.000197	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betaxolol—glaucoma	5.62e-05	0.000197	CcSEcCtD
Paroxetine—Fatigue—Betaxolol—glaucoma	5.61e-05	0.000197	CcSEcCtD
Paroxetine—Pain—Betaxolol—glaucoma	5.57e-05	0.000195	CcSEcCtD
Paroxetine—Constipation—Betaxolol—glaucoma	5.57e-05	0.000195	CcSEcCtD
Paroxetine—Nausea—Pilocarpine—glaucoma	5.56e-05	0.000195	CcSEcCtD
Paroxetine—Chest pain—Timolol—glaucoma	5.55e-05	0.000195	CcSEcCtD
Paroxetine—Myalgia—Timolol—glaucoma	5.55e-05	0.000195	CcSEcCtD
Paroxetine—Arthralgia—Timolol—glaucoma	5.55e-05	0.000195	CcSEcCtD
Paroxetine—Anxiety—Timolol—glaucoma	5.53e-05	0.000194	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	5.51e-05	0.000193	CcSEcCtD
Paroxetine—Hypersensitivity—Clonidine—glaucoma	5.51e-05	0.000193	CcSEcCtD
Paroxetine—Discomfort—Timolol—glaucoma	5.48e-05	0.000192	CcSEcCtD
Paroxetine—Dry mouth—Timolol—glaucoma	5.43e-05	0.00019	CcSEcCtD
Paroxetine—Asthenia—Clonidine—glaucoma	5.36e-05	0.000188	CcSEcCtD
Paroxetine—Feeling abnormal—Betaxolol—glaucoma	5.36e-05	0.000188	CcSEcCtD
Paroxetine—Confusional state—Timolol—glaucoma	5.36e-05	0.000188	CcSEcCtD
Paroxetine—Anaphylactic shock—Timolol—glaucoma	5.32e-05	0.000186	CcSEcCtD
Paroxetine—Oedema—Timolol—glaucoma	5.32e-05	0.000186	CcSEcCtD
Paroxetine—Pruritus—Clonidine—glaucoma	5.29e-05	0.000186	CcSEcCtD
Paroxetine—Infection—Timolol—glaucoma	5.28e-05	0.000185	CcSEcCtD
Paroxetine—Shock—Timolol—glaucoma	5.23e-05	0.000183	CcSEcCtD
Paroxetine—Nervous system disorder—Timolol—glaucoma	5.22e-05	0.000183	CcSEcCtD
Paroxetine—Urticaria—Betaxolol—glaucoma	5.17e-05	0.000181	CcSEcCtD
Paroxetine—Skin disorder—Timolol—glaucoma	5.17e-05	0.000181	CcSEcCtD
Paroxetine—Body temperature increased—Betaxolol—glaucoma	5.15e-05	0.00018	CcSEcCtD
Paroxetine—Hyperhidrosis—Timolol—glaucoma	5.14e-05	0.00018	CcSEcCtD
Paroxetine—Diarrhoea—Clonidine—glaucoma	5.12e-05	0.000179	CcSEcCtD
Paroxetine—Hypotension—Timolol—glaucoma	4.97e-05	0.000174	CcSEcCtD
Paroxetine—Dizziness—Clonidine—glaucoma	4.94e-05	0.000173	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Timolol—glaucoma	4.85e-05	0.00017	CcSEcCtD
Paroxetine—Insomnia—Timolol—glaucoma	4.81e-05	0.000169	CcSEcCtD
Paroxetine—Hypersensitivity—Betaxolol—glaucoma	4.8e-05	0.000168	CcSEcCtD
Paroxetine—Paraesthesia—Timolol—glaucoma	4.78e-05	0.000167	CcSEcCtD
Paroxetine—Vomiting—Clonidine—glaucoma	4.75e-05	0.000167	CcSEcCtD
Paroxetine—Dyspnoea—Timolol—glaucoma	4.74e-05	0.000166	CcSEcCtD
Paroxetine—Somnolence—Timolol—glaucoma	4.73e-05	0.000166	CcSEcCtD
Paroxetine—Rash—Clonidine—glaucoma	4.71e-05	0.000165	CcSEcCtD
Paroxetine—Dermatitis—Clonidine—glaucoma	4.71e-05	0.000165	CcSEcCtD
Paroxetine—Headache—Clonidine—glaucoma	4.68e-05	0.000164	CcSEcCtD
Paroxetine—Dyspepsia—Timolol—glaucoma	4.68e-05	0.000164	CcSEcCtD
Paroxetine—Asthenia—Betaxolol—glaucoma	4.67e-05	0.000164	CcSEcCtD
Paroxetine—Decreased appetite—Timolol—glaucoma	4.62e-05	0.000162	CcSEcCtD
Paroxetine—Pruritus—Betaxolol—glaucoma	4.61e-05	0.000162	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Timolol—glaucoma	4.59e-05	0.000161	CcSEcCtD
Paroxetine—Fatigue—Timolol—glaucoma	4.58e-05	0.000161	CcSEcCtD
Paroxetine—Pain—Timolol—glaucoma	4.55e-05	0.000159	CcSEcCtD
Paroxetine—Diarrhoea—Betaxolol—glaucoma	4.45e-05	0.000156	CcSEcCtD
Paroxetine—Nausea—Clonidine—glaucoma	4.44e-05	0.000156	CcSEcCtD
Paroxetine—Feeling abnormal—Timolol—glaucoma	4.38e-05	0.000154	CcSEcCtD
Paroxetine—Gastrointestinal pain—Timolol—glaucoma	4.35e-05	0.000152	CcSEcCtD
Paroxetine—Dizziness—Betaxolol—glaucoma	4.3e-05	0.000151	CcSEcCtD
Paroxetine—Urticaria—Timolol—glaucoma	4.22e-05	0.000148	CcSEcCtD
Paroxetine—Body temperature increased—Timolol—glaucoma	4.2e-05	0.000147	CcSEcCtD
Paroxetine—Abdominal pain—Timolol—glaucoma	4.2e-05	0.000147	CcSEcCtD
Paroxetine—Vomiting—Betaxolol—glaucoma	4.14e-05	0.000145	CcSEcCtD
Paroxetine—Rash—Betaxolol—glaucoma	4.1e-05	0.000144	CcSEcCtD
Paroxetine—Dermatitis—Betaxolol—glaucoma	4.1e-05	0.000144	CcSEcCtD
Paroxetine—Headache—Betaxolol—glaucoma	4.08e-05	0.000143	CcSEcCtD
Paroxetine—Hypersensitivity—Timolol—glaucoma	3.92e-05	0.000137	CcSEcCtD
Paroxetine—Nausea—Betaxolol—glaucoma	3.87e-05	0.000136	CcSEcCtD
Paroxetine—Asthenia—Timolol—glaucoma	3.82e-05	0.000134	CcSEcCtD
Paroxetine—Pruritus—Timolol—glaucoma	3.76e-05	0.000132	CcSEcCtD
Paroxetine—Diarrhoea—Timolol—glaucoma	3.64e-05	0.000128	CcSEcCtD
Paroxetine—Dizziness—Timolol—glaucoma	3.52e-05	0.000123	CcSEcCtD
Paroxetine—Vomiting—Timolol—glaucoma	3.38e-05	0.000119	CcSEcCtD
Paroxetine—Rash—Timolol—glaucoma	3.35e-05	0.000118	CcSEcCtD
Paroxetine—Dermatitis—Timolol—glaucoma	3.35e-05	0.000117	CcSEcCtD
Paroxetine—Headache—Timolol—glaucoma	3.33e-05	0.000117	CcSEcCtD
Paroxetine—Nausea—Timolol—glaucoma	3.16e-05	0.000111	CcSEcCtD
Paroxetine—CYP2B6—Metabolism—CA2—glaucoma	2.68e-05	0.000411	CbGpPWpGaD
Paroxetine—HTR2A—GPCR ligand binding—C3—glaucoma	2.66e-05	0.000408	CbGpPWpGaD
Paroxetine—CHRM1—GPCR ligand binding—C3—glaucoma	2.65e-05	0.000406	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.65e-05	0.000406	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—HDAC9—glaucoma	2.64e-05	0.000405	CbGpPWpGaD
Paroxetine—CHRM3—GPCR ligand binding—C3—glaucoma	2.64e-05	0.000405	CbGpPWpGaD
Paroxetine—HTR2A—SIDS Susceptibility Pathways—TNF—glaucoma	2.63e-05	0.000403	CbGpPWpGaD
Paroxetine—CHRM2—GPCR ligand binding—C3—glaucoma	2.61e-05	0.000401	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—C3—glaucoma	2.59e-05	0.000398	CbGpPWpGaD
Paroxetine—CHRM2—SIDS Susceptibility Pathways—TNF—glaucoma	2.58e-05	0.000396	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—EDN1—glaucoma	2.54e-05	0.00039	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—HDAC9—glaucoma	2.53e-05	0.000388	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CA1—glaucoma	2.48e-05	0.00038	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—EDN1—glaucoma	2.43e-05	0.000373	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—APOE—glaucoma	2.41e-05	0.00037	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CTSA—glaucoma	2.4e-05	0.000368	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CAV1—glaucoma	2.39e-05	0.000367	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—SMO—glaucoma	2.37e-05	0.000364	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—SMO—glaucoma	2.36e-05	0.000362	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—SMO—glaucoma	2.35e-05	0.000361	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—SMO—glaucoma	2.33e-05	0.000357	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—EDN1—glaucoma	2.31e-05	0.000354	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—FN1—glaucoma	2.28e-05	0.000349	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CA2—glaucoma	2.27e-05	0.000348	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—BAD—glaucoma	2.25e-05	0.000345	CbGpPWpGaD
Paroxetine—CHRM4—GPCR downstream signaling—C3—glaucoma	2.22e-05	0.00034	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.22e-05	0.00034	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.22e-05	0.00034	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—EDN1—glaucoma	2.21e-05	0.000339	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—TXN—glaucoma	2.19e-05	0.000336	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RPTOR—glaucoma	2.18e-05	0.000334	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RPTOR—glaucoma	2.16e-05	0.000332	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CA1—glaucoma	2.16e-05	0.000331	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RPTOR—glaucoma	2.16e-05	0.000331	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RPTOR—glaucoma	2.14e-05	0.000328	CbGpPWpGaD
Paroxetine—CHRM5—GPCR downstream signaling—C3—glaucoma	2.13e-05	0.000326	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NCK2—glaucoma	2.11e-05	0.000323	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NCK2—glaucoma	2.1e-05	0.000321	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CTSA—glaucoma	2.09e-05	0.000321	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NCK2—glaucoma	2.09e-05	0.00032	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2.08e-05	0.000319	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NCK2—glaucoma	2.07e-05	0.000317	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SMO—glaucoma	2.07e-05	0.000317	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CA1—glaucoma	2.03e-05	0.000312	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CA1—glaucoma	2.02e-05	0.000309	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—C3—glaucoma	2.02e-05	0.000309	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SMO—glaucoma	1.98e-05	0.000304	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CA2—glaucoma	1.98e-05	0.000303	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.97e-05	0.000303	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CTSA—glaucoma	1.97e-05	0.000302	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CTSA—glaucoma	1.95e-05	0.0003	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—C3—glaucoma	1.93e-05	0.000296	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NTRK2—glaucoma	1.89e-05	0.00029	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—TXN—glaucoma	1.89e-05	0.000289	CbGpPWpGaD
Paroxetine—CHRM1—Circadian rythm related genes—TP53—glaucoma	1.88e-05	0.000289	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CA2—glaucoma	1.86e-05	0.000285	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CA2—glaucoma	1.85e-05	0.000283	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NTRK2—glaucoma	1.81e-05	0.000278	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—NOS3—glaucoma	1.81e-05	0.000277	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.8e-05	0.000277	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.8e-05	0.000277	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—HDAC9—glaucoma	1.79e-05	0.000275	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—HDAC9—glaucoma	1.78e-05	0.000273	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—HDAC9—glaucoma	1.78e-05	0.000272	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—HDAC9—glaucoma	1.76e-05	0.00027	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—EDN1—glaucoma	1.72e-05	0.000264	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—EDN1—glaucoma	1.71e-05	0.000263	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—EDN1—glaucoma	1.71e-05	0.000262	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GSTT1—glaucoma	1.7e-05	0.000261	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—EDN1—glaucoma	1.69e-05	0.000259	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.64e-05	0.000252	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NGFR—glaucoma	1.62e-05	0.000249	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—TXN—glaucoma	1.6e-05	0.000245	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—CDKN1B—glaucoma	1.57e-05	0.00024	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—EDN1—glaucoma	1.56e-05	0.00024	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—EDN1—glaucoma	1.56e-05	0.000239	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NGFR—glaucoma	1.55e-05	0.000238	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—EDN1—glaucoma	1.55e-05	0.000238	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NTRK1—glaucoma	1.54e-05	0.000236	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—EDN1—glaucoma	1.54e-05	0.000236	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—C3—glaucoma	1.5e-05	0.000231	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—C3—glaucoma	1.5e-05	0.00023	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—C3—glaucoma	1.49e-05	0.000229	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—C3—glaucoma	1.48e-05	0.000227	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NTRK1—glaucoma	1.48e-05	0.000226	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GSTT1—glaucoma	1.46e-05	0.000224	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.46e-05	0.000223	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—MMP9—glaucoma	1.45e-05	0.000223	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.44e-05	0.000221	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CDKN2B—glaucoma	1.42e-05	0.000218	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.41e-05	0.000216	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SMO—glaucoma	1.4e-05	0.000215	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SMO—glaucoma	1.39e-05	0.000214	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—TXN—glaucoma	1.39e-05	0.000213	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SMO—glaucoma	1.39e-05	0.000213	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SMO—glaucoma	1.38e-05	0.000211	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—C3—glaucoma	1.37e-05	0.00021	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EDN1—glaucoma	1.36e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CDKN2B—glaucoma	1.36e-05	0.000209	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—C3—glaucoma	1.36e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—C3—glaucoma	1.35e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CYP1B1—glaucoma	1.35e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ABCA1—glaucoma	1.35e-05	0.000208	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—C3—glaucoma	1.34e-05	0.000206	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—TXN—glaucoma	1.31e-05	0.000201	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EDN1—glaucoma	1.31e-05	0.0002	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—VEGFA—glaucoma	1.3e-05	0.0002	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—TXN—glaucoma	1.3e-05	0.000199	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NTRK2—glaucoma	1.28e-05	0.000197	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NTRK2—glaucoma	1.28e-05	0.000196	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NTRK2—glaucoma	1.27e-05	0.000195	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NTRK2—glaucoma	1.26e-05	0.000193	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NGF—glaucoma	1.25e-05	0.000192	CbGpPWpGaD
Paroxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.24e-05	0.00019	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTT1—glaucoma	1.24e-05	0.00019	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NGF—glaucoma	1.2e-05	0.000184	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—C3—glaucoma	1.19e-05	0.000183	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.19e-05	0.000182	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.18e-05	0.00018	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ABCA1—glaucoma	1.17e-05	0.000179	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CYP1B1—glaucoma	1.17e-05	0.000179	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—C3—glaucoma	1.14e-05	0.000175	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—APOE—glaucoma	1.11e-05	0.00017	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NGFR—glaucoma	1.1e-05	0.000169	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CAV1—glaucoma	1.1e-05	0.000168	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NGFR—glaucoma	1.09e-05	0.000168	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NGFR—glaucoma	1.09e-05	0.000167	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—GSTM1—glaucoma	1.08e-05	0.000166	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NGFR—glaucoma	1.08e-05	0.000166	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTT1—glaucoma	1.08e-05	0.000165	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—APOE—glaucoma	1.06e-05	0.000163	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CAV1—glaucoma	1.05e-05	0.000161	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—FN1—glaucoma	1.05e-05	0.00016	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NTRK1—glaucoma	1.05e-05	0.00016	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NTRK1—glaucoma	1.04e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NTRK1—glaucoma	1.04e-05	0.000159	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—BAD—glaucoma	1.03e-05	0.000158	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NTRK1—glaucoma	1.03e-05	0.000157	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTT1—glaucoma	1.02e-05	0.000156	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTT1—glaucoma	1.01e-05	0.000155	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—FN1—glaucoma	1e-05	0.000154	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	9.99e-06	0.000153	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—BAD—glaucoma	9.89e-06	0.000152	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ABCA1—glaucoma	9.87e-06	0.000151	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CYP1B1—glaucoma	9.87e-06	0.000151	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—TP53—glaucoma	9.85e-06	0.000151	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CDKN2B—glaucoma	9.63e-06	0.000148	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CDKN2B—glaucoma	9.58e-06	0.000147	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—MTHFR—glaucoma	9.57e-06	0.000147	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CDKN2B—glaucoma	9.55e-06	0.000146	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CDKN2B—glaucoma	9.46e-06	0.000145	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GSTM1—glaucoma	9.32e-06	0.000143	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EDN1—glaucoma	9.24e-06	0.000142	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EDN1—glaucoma	9.19e-06	0.000141	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EDN1—glaucoma	9.16e-06	0.000141	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EDN1—glaucoma	9.07e-06	0.000139	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—APOE—glaucoma	8.91e-06	0.000137	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—CAV1—glaucoma	8.83e-06	0.000135	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CYP1B1—glaucoma	8.6e-06	0.000132	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ABCA1—glaucoma	8.6e-06	0.000132	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NGF—glaucoma	8.49e-06	0.00013	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NGF—glaucoma	8.45e-06	0.00013	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NGF—glaucoma	8.42e-06	0.000129	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NGF—glaucoma	8.34e-06	0.000128	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NOS3—glaucoma	8.31e-06	0.000127	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—MTHFR—glaucoma	8.24e-06	0.000126	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.13e-06	0.000125	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ABCA1—glaucoma	8.1e-06	0.000124	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CYP1B1—glaucoma	8.1e-06	0.000124	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—C3—glaucoma	8.07e-06	0.000124	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CYP1B1—glaucoma	8.03e-06	0.000123	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ABCA1—glaucoma	8.03e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—C3—glaucoma	8.03e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—C3—glaucoma	8e-06	0.000123	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NOS3—glaucoma	7.95e-06	0.000122	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—C3—glaucoma	7.93e-06	0.000122	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTM1—glaucoma	7.89e-06	0.000121	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—APOE—glaucoma	7.67e-06	0.000118	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—CAV1—glaucoma	7.6e-06	0.000116	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—APOE—glaucoma	7.52e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—APOE—glaucoma	7.48e-06	0.000115	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—APOE—glaucoma	7.45e-06	0.000114	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CAV1—glaucoma	7.45e-06	0.000114	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CAV1—glaucoma	7.41e-06	0.000114	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CAV1—glaucoma	7.38e-06	0.000113	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—APOE—glaucoma	7.38e-06	0.000113	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CAV1—glaucoma	7.31e-06	0.000112	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CDKN1B—glaucoma	7.2e-06	0.00011	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FN1—glaucoma	7.09e-06	0.000109	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FN1—glaucoma	7.05e-06	0.000108	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FN1—glaucoma	7.03e-06	0.000108	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—BAD—glaucoma	7e-06	0.000107	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—MTHFR—glaucoma	6.97e-06	0.000107	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—BAD—glaucoma	6.97e-06	0.000107	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FN1—glaucoma	6.96e-06	0.000107	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—BAD—glaucoma	6.94e-06	0.000106	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CDKN1B—glaucoma	6.89e-06	0.000106	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—BAD—glaucoma	6.88e-06	0.000105	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTM1—glaucoma	6.87e-06	0.000105	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—glaucoma	6.68e-06	0.000102	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—glaucoma	6.66e-06	0.000102	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—APOE—glaucoma	6.49e-06	9.95e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTM1—glaucoma	6.48e-06	9.93e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CAV1—glaucoma	6.43e-06	9.86e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTM1—glaucoma	6.42e-06	9.85e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—glaucoma	6.38e-06	9.79e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—glaucoma	6.11e-06	9.36e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—MTHFR—glaucoma	6.07e-06	9.31e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—glaucoma	5.98e-06	9.18e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—glaucoma	5.74e-06	8.81e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—glaucoma	5.73e-06	8.79e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—MTHFR—glaucoma	5.72e-06	8.78e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—MTHFR—glaucoma	5.67e-06	8.7e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—APOE—glaucoma	5.65e-06	8.67e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—glaucoma	5.63e-06	8.63e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAV1—glaucoma	5.6e-06	8.59e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—glaucoma	5.6e-06	8.59e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—glaucoma	5.58e-06	8.56e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—glaucoma	5.53e-06	8.48e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—APOE—glaucoma	5.33e-06	8.17e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—APOE—glaucoma	5.28e-06	8.1e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAV1—glaucoma	5.28e-06	8.1e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—glaucoma	5.25e-06	8.06e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAV1—glaucoma	5.23e-06	8.03e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CDKN1B—glaucoma	4.88e-06	7.48e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—glaucoma	4.86e-06	7.46e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CDKN1B—glaucoma	4.85e-06	7.44e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CDKN1B—glaucoma	4.84e-06	7.42e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CDKN1B—glaucoma	4.79e-06	7.34e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TP53—glaucoma	4.52e-06	6.93e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—glaucoma	4.52e-06	6.93e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—glaucoma	4.49e-06	6.89e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—glaucoma	4.48e-06	6.87e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—glaucoma	4.45e-06	6.82e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—glaucoma	4.44e-06	6.8e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TP53—glaucoma	4.33e-06	6.64e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—glaucoma	4.24e-06	6.5e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—glaucoma	4.06e-06	6.22e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—glaucoma	4.03e-06	6.19e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—glaucoma	4.02e-06	6.17e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—glaucoma	3.99e-06	6.12e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—glaucoma	3.98e-06	6.11e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—glaucoma	3.96e-06	6.07e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—glaucoma	3.87e-06	5.94e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—glaucoma	3.65e-06	5.6e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—glaucoma	3.62e-06	5.55e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TP53—glaucoma	3.07e-06	4.7e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TP53—glaucoma	3.05e-06	4.68e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TP53—glaucoma	3.04e-06	4.66e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TP53—glaucoma	3.01e-06	4.62e-05	CbGpPWpGaD
